KCNE1 rs1805128: What Your Genotype Means
The rs1805128 variant, commonly known as D85N, is a genetic change in the KCNE1 gene that alters a protein involved in heart rhythm regulation. Research suggests that individuals carrying this variant may have an increased susceptibility to drug-induced long QT syndrome, a condition where certain medications cause dangerous heart rhythm irregularities.
What each genotype means
Typical drug response profile
This is the most common genotype for this variant. Research suggests that individuals with this genotype do not carry the D85N variant associated with increased susceptibility to drug-induced long QT syndrome. Always consult your clinician or pharmacist regarding the safety of any medication, regardless of your genetic profile.
This is the predominant genotype across all major global populations.
Increased drug-induced risk
This genotype includes the D85N variant, which has been associated in some studies with an increased risk of drug-induced long QT syndrome and torsades de pointes when taking certain QT-prolonging medications. Because this variant is relatively common, it is generally considered a risk modulator rather than a sole cause of disease. Please discuss this finding with your healthcare provider or pharmacist to ensure your medication choices are appropriate for your health profile.
Carried by approximately 1-2% of individuals of European ancestry, with lower frequencies observed in East Asian and African populations.
Increased drug-induced risk
This genotype indicates the presence of two copies of the D85N variant. Research suggests this variant may increase susceptibility to drug-induced long QT syndrome and torsades de pointes when exposed to specific medications that prolong the QT interval. You should discuss this result with your clinician or pharmacist to manage potential risks associated with future medication use.
This genotype is very rare across all studied populations.
Understanding the rs1805128 Variant
The rs1805128 variant is a single-nucleotide polymorphism (SNP) located within the KCNE1 gene. In genetic terms, this variant represents a change where the DNA base cytosine (C) is replaced by thymine (T). This specific change results in an amino acid substitution in the resulting protein, where aspartic acid (D) is replaced by asparagine (N) at position 85, which is why it is frequently referred to in scientific literature as the D85N variant. This gene is located on chromosome 21 and provides instructions for creating a small protein that acts as a regulatory subunit for potassium channels in the heart. Because these channels are essential for the electrical activity that coordinates each heartbeat, changes in the protein structure can potentially influence how the heart responds to electrical signals and, consequently, how it reacts to certain external factors like medications.
The Role of the KCNE1 Gene
The KCNE1 gene encodes a protein known as MinK, which functions as a critical partner for the KCNQ1 potassium channel. Together, these proteins form a complex that generates the slow delayed rectifier potassium current, often abbreviated as IKs. This current is vital for the repolarization phase of the cardiac action potential, which is the process that allows heart muscle cells to reset their electrical charge after each contraction. By facilitating this reset, the KCNE1-KCNQ1 complex ensures that the heart maintains a stable and appropriate rhythm. When the function of this channel is impaired, the heart may take longer to reset its electrical state, a phenomenon known as QT prolongation. Because many common medications—including certain antiarrhythmics, antibiotics, and antipsychotics—also interact with these cardiac channels, individuals with reduced repolarization reserve may be at a higher risk of experiencing rhythm disturbances when taking these drugs.
Research and Clinical Associations
Scientific research has investigated the link between the KCNE1 D85N variant and drug-induced long QT syndrome (diLQTS) and torsades de pointes, a specific type of life-threatening heart rhythm abnormality. Some studies have identified this variant as a potential modulator of risk, with certain reports suggesting a significant association with increased susceptibility to drug-induced rhythm issues. However, the evidence strength is considered limited or evolving, as findings have varied across different study designs and populations. While some functional studies in laboratory settings indicate that the D85N variant leads to a loss of function in potassium currents, clinical data often involve complex interactions between genetics, environment, and other medications. It is important to note that carrying this variant does not guarantee that an individual will experience a drug-induced heart rhythm issue, but it is recognized in some clinical contexts as a factor that may warrant increased attention when prescribing medications known to affect the QT interval.
Population Frequency
The rs1805128 variant is relatively uncommon in the general population. Data from large-scale genomic databases indicate that the minor allele frequency is approximately 1-2% across European populations, with slightly higher frequencies observed in some groups, such as Ashkenazi Jewish populations. The frequency is generally lower in East Asian and African ancestries. Because the variant is rare, the majority of the population carries the common C/C genotype. The presence of the T allele, which corresponds to the D85N change, is typically found in the heterozygous state (C/T) or, much more rarely, in the homozygous state (T/T). These frequency patterns highlight that while the variant is a known genetic feature, it is not a widespread trait, and its clinical relevance is most often discussed in the context of specific drug exposures rather than general health screening.
What This Information Means for You
If you are aware of your status regarding the rs1805128 variant, it is essential to interpret this information within the context of your overall health and medical history. Genetic variants are only one piece of a much larger puzzle that includes your age, underlying health conditions, and other medications you may be taking. This information should never be used to self-diagnose or to make decisions about stopping or starting any prescribed medication. If you have concerns about your genetic profile or your risk for drug-induced heart rhythm issues, the most appropriate step is to discuss this with your healthcare provider or a clinical pharmacist. They can evaluate your specific clinical situation, review your current medication list, and determine if any adjustments or additional monitoring are necessary to ensure your safety and well-being.
How common is this variant?
The rs1805128 variant has a minor allele frequency of approximately 1-2% across European populations, with lower frequencies observed in East Asian and African ancestries.
Frequently asked questions
Is the KCNE1 D85N variant a cause of long QT syndrome?
The D85N variant is considered a potential modulator of risk for drug-induced long QT syndrome. While it has been studied in the context of heart rhythm disorders, it is generally viewed as a susceptibility factor rather than a direct, singular cause of the condition.
Should I get tested for the rs1805128 variant?
Routine genetic testing for this variant is not standard practice for the general population. If you have a personal or family history of unexplained heart rhythm issues or are concerned about medication side effects, consult your doctor to see if genetic counseling or testing is appropriate for you.
Does having the C/T genotype mean I will have a heart attack?
No, the C/T genotype is not a direct cause of heart attacks. It is associated with the heart's electrical repolarization process and may influence how you respond to certain medications that affect the QT interval.
What medications should I avoid if I have this variant?
There is no universal list of medications to avoid based solely on this variant. You must discuss your specific genetic results and your current medication list with your healthcare provider, who can assess your individual risk profile.
Sources & further reading
Educational information only, last refreshed 10/13/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1805128?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29